Literature DB >> 24117274

The comorbidity of ADHD and autism spectrum disorder.

Kevin M Antshel1, Yanli Zhang-James, Stephen V Faraone.   

Abstract

ADHD and autism spectrum disorder are common psychiatric comorbidities to each another. In addition, there is behavioral, biological and neuropsychological overlap between the two disorders. There are also several important differences between autism spectrum disorder and ADHD. Treatment strategies for the comorbid condition will also be reviewed. Future areas of research and clinical need will be discussed.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24117274     DOI： 10.1586/14737175.2013.840417

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


  37 in total

1.  Brief Report: The Negev Hospital-University-Based (HUB) Autism Database.

Authors:  Gal Meiri; Ilan Dinstein; Analya Michaelowski; Hagit Flusser; Michal Ilan; Michal Faroy; Asif Bar-Sinai; Liora Manelis; Dana Stolowicz; Lili Lea Yosef; Nadav Davidovitch; Hava Golan; Shosh Arbelle; Idan Menashe
Journal:  J Autism Dev Disord       Date:  2017-09

2.  The Co-Occurrence of Autism Spectrum Disorder in Children With ADHD.

Authors:  Benjamin Zablotsky; Matthew D Bramlett; Stephen J Blumberg
Journal:  J Atten Disord       Date:  2017-06-14       Impact factor: 3.256

3.  Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.

Authors:  Marco Lamberti; Rosamaria Siracusano; Domenico Italiano; Norma Alosi; Francesca Cucinotta; Gabriella Di Rosa; Eva Germanò; Edoardo Spina; Antonella Gagliano
Journal:  Paediatr Drugs       Date:  2016-08       Impact factor: 3.022

4.  Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism.

Authors:  Rameshwari V Tumuluru; Patricia Corbett-Dick; Michael G Aman; Tristram Smith; L Eugene Arnold; Xueliang Pan; Kristin A Buchan-Page; Nicole V Brown; Melissa M Ryan; Susan L Hyman; Jessica Hellings; Craig Williams; Jill A Hollway; Luc Lecavalier; Robert R Rice; Sarah McAuliffe-Bellin; Benjamin L Handen
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-05-16       Impact factor: 2.576

5.  Using the PDD Behavior Inventory as a Level 2 Screener: A Classification and Regression Trees Analysis.

Authors:  Ira L Cohen; Xudong Liu; Melissa Hudson; Jennifer Gillis; Rachel N S Cavalari; Raymond G Romanczyk; Bernard Z Karmel; Judith M Gardner
Journal:  J Autism Dev Disord       Date:  2016-09

6.  Elevated burden for caregivers of children with persistent asthma and a developmental disability.

Authors:  Alana D Koehler; Maria Fagnano; Guillermo Montes; Jill S Halterman
Journal:  Matern Child Health J       Date:  2014-11

7.  Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus.

Authors:  Susan Young; Jack Hollingdale; Michael Absoud; Patrick Bolton; Polly Branney; William Colley; Emily Craze; Mayuri Dave; Quinton Deeley; Emad Farrag; Gisli Gudjonsson; Peter Hill; Ho-Lan Liang; Clodagh Murphy; Peri Mackintosh; Marianna Murin; Fintan O'Regan; Dennis Ougrin; Patricia Rios; Nancy Stover; Eric Taylor; Emma Woodhouse
Journal:  BMC Med       Date:  2020-05-25       Impact factor: 8.775

8.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

9.  Comprehensive Description of Comorbidity for Autism Spectrum Disorder in a General Population.

Authors:  David Cawthorpe
Journal:  Perm J       Date:  2017

Review 10.  Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms.

Authors:  Eduardo F Gallo; Jonathan Posner
Journal:  Lancet Psychiatry       Date:  2016-05-13       Impact factor: 27.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.